- Home
- TARS vs PENN Comparison
TARS vs PENN Comparison
Compare TARS & PENN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TARS | PENN |
|---|---|---|
| Founded | 2016 | 1972 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Hotels/Resorts |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.8B |
| IPO Year | 2020 | 1994 |
Fundamental Metrics
Financial Performance| Metric | TARS | PENN |
|---|---|---|
| Price | $81.11 | $13.79 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 18 |
| Target Price | ★ $76.56 | $21.94 |
| AVG Volume (30 Days) | 404.5K | ★ 3.2M |
| Earning Date | 11-04-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $366,100,000.00 | ★ $6,823,800,000.00 |
| Revenue This Year | $147.24 | $7.23 |
| Revenue Next Year | $53.11 | $3.25 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 182.44 | 8.24 |
| 52 Week Low | $38.51 | $13.24 |
| 52 Week High | $85.25 | $23.08 |
Technical Indicators
Market Signals| Indicator | TARS | PENN |
|---|---|---|
| Relative Strength Index (RSI) | 59.46 | 34.87 |
| Support Level | $77.44 | $13.59 |
| Resistance Level | $85.25 | $15.07 |
| Average True Range (ATR) | 3.56 | 0.49 |
| MACD | -0.32 | 0.04 |
| Stochastic Oscillator | 55.84 | 15.94 |
Price Performance
Historical ComparisonAbout TARS Tarsus Pharmaceuticals Inc.
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.
About PENN PENN Entertainment Inc.
Penn Entertainment's origins date back to its 1972 racetrack opening in Pennsylvania. Today, Penn operates 43 properties across 20 states and 12 brands, including Hollywood Casino and Ameristar. Land-based casinos represented 85% of total sales in 2024; 15% was from the interactive segment, which includes sports, iGaming, and media revenue. The retail portfolio generates mid-30s EBITDAR margins and helps position the company to obtain licenses for the digital wagering markets. Additionally, Penn's media assets, theScore and ESPN (starting with its partnership launch in November 2023), provide access to sports betting/iGaming technology and clientele, helping it form a leading digital position.